Evidence map›Paper›PMID 38756893›Full record

ArticleFrontiers in public health2024

Predicting the prevalence of type 2 diabetes in Brazil: a modeling study.

Patrícia Vasconcelos Leitão Moreira, Adélia da Costa Pereira de Arruda Neta, Flávia Emília Leite Lima Ferreira, Jevuks Matheus de Araújo, Rômulo Eufrosino de Alencar Rodrigues, Rafaela Lira Formiga Cavalcanti de Lima, Rodrigo Pinheiro de Toledo Vianna, José Moreira da Silva Neto, Martin O'Flaherty

Abstract read
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Patrícia Vasconcelos Leitão MoreiraDepartment of Nutrition, Federal University of Paraiba, João Pessoa, Paraíba, Brazil.
Adélia da Costa Pereira de Arruda NetaDepartment of Nutrition, Federal University of Paraiba, João Pessoa, Paraíba, Brazil.
Flávia Emília Leite Lima FerreiraDepartment of Nutrition, Federal University of Paraiba, João Pessoa, Paraíba, Brazil.
Jevuks Matheus de AraújoDepartment of Economy, Federal University of Paraiba, João Pessoa, Paraíba, Brazil.
Rômulo Eufrosino de Alencar RodriguesDepartment of Economy, Federal University of Paraiba, João Pessoa, Paraíba, Brazil.
Rafaela Lira Formiga Cavalcanti de LimaDepartment of Nutrition, Federal University of Paraiba, João Pessoa, Paraíba, Brazil.
Rodrigo Pinheiro de Toledo ViannaDepartment of Nutrition, Federal University of Paraiba, João Pessoa, Paraíba, Brazil.
José Moreira da Silva NetoTechnical School of Health of the Federal University of Paraíba, João Pessoa, Paraíba, Brazil.
Martin O'FlahertyDepartment of Public Health and Policy, University of Liverpool, Liverpool, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: We adopted a modeling approach to predict the likely future prevalence of type 2 diabetes, taking into account demographic changes and trends in obesity and smoking in Brazil. We then used the model to estimate the likely future impact of different policy scenarios, such as policies to reduce obesity. Methods: The IMPACT TYPE 2 DIABETES model uses a Markov approach to integrate population, obesity, and smoking trends to estimate future type 2 diabetes prevalence. We developed a model for the Brazilian population from 2006 to 2036. Data on the Brazilian population in relation to sex and age were collected from the Brazilian Institute of Geography and Statistics, and data on the prevalence of type 2 diabetes, obesity, and smoking were collected from the Surveillance of Risk and Protection Factors for Chronic Diseases by Telephone Survey (VIGITEL). Results: The observed prevalence of type 2 diabetes among Brazilians aged over 25 years was 10.8% (5.2-14.3%) in 2006, increasing to 13.7% (6.9-18.4%) in 2020. Between 2006 and 2020, the observed prevalence in men increased from 11.0 to 19.1% and women from 10.6 to 21.3%. The model forecasts a dramatic rise in prevalence by 2036 (27.0% overall, 17.1% in men and 35.9% in women). However, if obesity prevalence declines by 1% per year from 2020 to 2036 (Scenario 1), the prevalence of diabetes decreases from 26.3 to 23.7, which represents approximately a 10.0% drop in 16 years. If obesity declined by 5% per year in 16 years as an optimistic target (Scenario 2), the prevalence of diabetes decreased from 26.3 to 21.2, representing a 19.4% drop in diabetes prevalence. Conclusion: The model predicts an increase in the prevalence of type 2 diabetes in Brazil. Even with ambitious targets to reduce obesity prevalence, type 2 diabetes in Brazil will continue to have a large impact on Brazilian public health.

Indexed as

Diabetes Mellitus, Type 2ObesityAdultAgedBrazilFemaleForecastingHumansMaleMarkov ChainsMiddle AgedPrevalenceRisk FactorsSmokingdemographic changesmodelingobesity trendsprojectiontarget strategiestype 2 diabetes prevalence

Identifiers

PMID38756893
PMCPMC11096587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.